254 related articles for article (PubMed ID: 16733616)
1. Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease.
Karlsson RM; Holmes A
Amino Acids; 2006 Oct; 31(3):231-9. PubMed ID: 16733616
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice.
Karlsson RM; Holmes A; Heilig M; Crawley JN
Pharmacol Biochem Behav; 2005 Mar; 80(3):427-36. PubMed ID: 15740785
[TBL] [Abstract][Full Text] [Related]
4. One for all or one for one: does co-transmission unify the concept of a brain galanin "system" or clarify any consistent role in anxiety?
Barrera G; Echevarria DJ; Poulin JF; Laforest S; Drolet G; Morilak DA
Neuropeptides; 2005 Jun; 39(3):289-92. PubMed ID: 15944024
[TBL] [Abstract][Full Text] [Related]
5. The role of galanin system in modulating depression, anxiety, and addiction-like behaviors after chronic restraint stress.
Zhao X; Seese RR; Yun K; Peng T; Wang Z
Neuroscience; 2013 Aug; 246():82-93. PubMed ID: 23639882
[TBL] [Abstract][Full Text] [Related]
6. Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs.
Hayase T
BMC Neurosci; 2007 Sep; 8():76. PubMed ID: 17877812
[TBL] [Abstract][Full Text] [Related]
7. The role of galanin in modulating stress-related neural pathways.
Wrenn CC; Holmes A
Drug News Perspect; 2006 Oct; 19(8):461-7. PubMed ID: 17160146
[TBL] [Abstract][Full Text] [Related]
8. Galanin, galanin receptor subtypes and depression-like behaviour.
Kuteeva E; Hökfelt T; Wardi T; Ogren SO
Exp Suppl; 2010; 102():163-81. PubMed ID: 21299068
[TBL] [Abstract][Full Text] [Related]
9. Galanin function in the central nervous system.
Walton KM; Chin JE; Duplantier AJ; Mather RJ
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):560-70. PubMed ID: 17002216
[TBL] [Abstract][Full Text] [Related]
10. The role of the galaninergic system in modulating stress-related responses in an animal model of posttraumatic stress disorder.
Kozlovsky N; Matar MA; Kaplan Z; Zohar J; Cohen H
Biol Psychiatry; 2009 Mar; 65(5):383-91. PubMed ID: 19095221
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
Palucha A; Pilc A
Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of neuropeptides in rodent models of depression and anxiety.
Rotzinger S; Lovejoy DA; Tan LA
Peptides; 2010 Apr; 31(4):736-56. PubMed ID: 20026211
[TBL] [Abstract][Full Text] [Related]
13. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.
Lu X; Mazarati A; Sanna P; Shinmei S; Bartfai T
Neuropeptides; 2005 Jun; 39(3):147-52. PubMed ID: 15944003
[TBL] [Abstract][Full Text] [Related]
14. Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze.
Holmes A; Kinney JW; Wrenn CC; Li Q; Yang RJ; Ma L; Vishwanath J; Saavedra MC; Innerfield CE; Jacoby AS; Shine J; Iismaa TP; Crawley JN
Neuropsychopharmacology; 2003 Jun; 28(6):1031-44. PubMed ID: 12700679
[TBL] [Abstract][Full Text] [Related]
15. Galanin modulating effect on restraint stress-induced short- and long-term behavioral changes in Wistar rats.
Klenerova V; Flegel M; Skopek P; Sida P; Hynie S
Neurosci Lett; 2011 Sep; 502(3):147-51. PubMed ID: 21763401
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba].
Tsuji M; Miyagawa K; Takeuchi T; Takeda H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):159-67. PubMed ID: 18800619
[TBL] [Abstract][Full Text] [Related]
18. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent.
Hughes ZA; Liu F; Platt BJ; Dwyer JM; Pulicicchio CM; Zhang G; Schechter LE; Rosenzweig-Lipson S; Day M
Neuropharmacology; 2008 Jun; 54(7):1136-42. PubMed ID: 18423777
[TBL] [Abstract][Full Text] [Related]
19. The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors: possible relevance for affective disorders.
Ogren SO; Razani H; Elvander-Tottie E; Kehr J
Physiol Behav; 2007 Sep; 92(1-2):172-9. PubMed ID: 17585970
[TBL] [Abstract][Full Text] [Related]
20. The role of substance P in stress and anxiety responses.
Ebner K; Singewald N
Amino Acids; 2006 Oct; 31(3):251-72. PubMed ID: 16820980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
